Pad Chivukula - Nov 1, 2021 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Signature
/s/ Ilan Katz, attorney-in-fact
Stock symbol
ARCT
Transactions as of
Nov 1, 2021
Transactions value $
-$444,100
Form type
4
Date filed
11/3/2021, 11:20 AM
Previous filing
Oct 4, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARCT Common Stock Sale -$444K -10K -1.61% $44.41 613K Nov 1, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on November 1, 2021 with sale prices ranging from $43.17 to $45.42 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.